La vendita allo scoperto per Beachbody Co dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Beachbody Co. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Beachbody Co (NYSE:BODI) Azioni, Report sulle vendite allo scoperto

Beachbody Co

The Beachbody Company, Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.

The Beachbody Co Inc

On Wednesday, November 6th, U.S. markets closed at record highs as Donald Trump won the 2024 presidential election. Investors anticipated lower taxes, deregulation, and Trump&#8217;s active stance on economic matters. The Dow, S&amp;P 500, and Nasdaq surged, while bitcoin also reached new highs.
Tesla shares surged, fueled by CEO Elon Musk&#8217;s endorsement of Trump, alongside gains in Trump Media &amp; Technology Group. Treasury yields rose amid expectations that higher tariffs could drive up inflation and expand the U.S. deficit.
According to economic data, U.S. mortgage applications dropped 10.8% last week, while crude oil inventories rose by 2.149 million barrels, exceeding the forecast of 1.8 million.
Most S&amp;P 500 sectors closed higher, led by consumer discretionary, industrials, and financials, while consumer staples and real estate lagged.
The Dow Jones Industrial Average gained 3,57% to close at 43,729.93, the S&amp;P 500 rose 2.53% to 5,929.04, and the Nasdaq Composite soared 2.95% to finish at 18,983.47.
Asia Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 declined 0.09% and ended the session at 39,394.00, led by losses in the Fishery, Marine Transport, and Food sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 rose 0.33% and ended the day at 8,226.30, led by gains in the Energy, Industrials and Financials sectors.</li>
<li>India&#8217;s Nifty 50 traded lower by 1.18% at 24,194.60 and Nifty 500 was down 1.02% at 22,796.95, losses in the Metals, Power and Real Estate sectors.</li>
<li>China&#8217;s Shanghai Composite gained 2.57% to close at 3,470.66, and the Shenzhen CSI 300 soared 3.02%, finishing the day at 4,145.70.</li>
<li>Hong Kong&#8217;s Hang Seng rose 2.02% and closed the session at 20,953.34.</li>
</ul>
Eurozone at 05.45 AM ET
<ul>
<li>The European STOXX 50 index was up 0.67%.</li>
<li>Germany&#8217;s DAX gained 1.27%.</li>
<li>France&#8217;s CAC rose 0.58%.</li>
<li>U.K.&#8217;s FTSE 100 traded higher by 0.08%.</li>
</ul>
Commodities at 05.45 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.88% at $71.06/bbl, and Brent was down 0.71% at $74.41/bbl.</li>
<li>Natural Gas slid 0.07% to $2.745</li>
<li>Gold was trading lower by 0.08% at $2,674.70, Silver fell 0.29% to $31.245, and Copper gained 2.28% to $4.3430.</li>
</ul>
U.S. Futures at 05.45 AM ET
Dow futures climbed 0.22%, with S&amp;P 500 futures up 0.19% and Nasdaq 100 futures rising 0.21%.
Forex at 05.45 AM ET
<ul>
<li>The U.S. dollar index declined 0.19% to 104.89, the USD/JPY was down 0.40% to 154.00, and the USD/AUD fell 0.89% to 1.5086.</li>
<li>Global stocks rose, led by optimism over potential U.S. fiscal expansion under Trump&#8217;s presidency and anticipated rate cuts from the Fed and other central banks. U.S. Treasury yields increased, while the dollar eased slightly after Wednesday&#8217;s surge.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

News

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

US Futures, European Stocks Rally Post-Trump Victory While Crude Oil And Gold Decline - Global Markets Today While US Slept

Fourth Quarter and Full Year 2024 Guidance&nbsp;
We expect fourth quarter 2024 revenue of $202-$204 million and Total Bookings of $224-$226 million.&nbsp;
For the full year of 2024, we expect to deliver expanding margins and Free Cash Flow growth of at least 40% versus 2023.

Earnings

Guidance

Clear Secure Expects Q4 Revenue Of $202M-$204M Vs. $200.35M Est; Bookings Of $224M-$226M

Under the FEED contract, KBR will provide engineering services for the complex's fourth LNG train, which will have a capacity of 3.8 million tons per annum. The project will involve the addition or expansion of utilities, an LNG tank, the jetty, and associated infrastructure.

Contracts

General

KBR Has Been Awarded A Front-end Engineering Design Contract For The Expansion Of The Qalhat LNG Complex In Sur, Oman

Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) raises FY2024 sales outlook from $1.64 billion-1.68 billion to $1.68 billion.

PRVA

Privia Health Gr expects FY24 revenue at high end of prior guidance range of $1.600-$1.675B vs. est. $1.83B.

HC Wainwright &amp; Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) with a Buy and maintains $16 price target.

Price Target

Reiteration

Analyst Ratings

SLDB

HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target

Townsquare Expects Q4 Net Revenue Of $114.8 Million And $118.8 Million (Est $121.299M), Narrows FY24 Outlook From $440M - $455M To $448M - $452M, Est $454.302M

Biotech

Health Care

AUPH

Aurinia Is Implementing A Strategic Restructuring That Will Result In A Workforce Reduction Of Approximately 45%, With Anticipated Post-restructuring Annualized Cash-based Operating Expense Savings Of More Than $40M

Geo Group Lowers FY24 Outlook: Sees Adjusted EPS $0.80-$0.84 Vs. $0.92 Estimate (Prior View: $0.82-$0.93), Projects Revenues Of $2.42B Vs. $2.44B Estimate (Prior View: $2.44B)

Fennec Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.10) by 110 percent. This is a 200 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $6.97 million which missed the analyst consensus estimate of $8.82 million by 20.93 percent. This is a 7.05 percent increase over sales of $6.51 million the same period last year.

FENC

Fennec Pharmaceuticals Q3 EPS $(0.21) Misses $(0.10) Estimate, Sales $6.97M Miss $8.82M Estimate

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) with a Buy and maintains $8 price target.

HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $8 Price Target

Truist Securities analyst Neal Dingmann downgrades Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) from Buy to Hold and lowers the price target from $49 to $43.

Downgrades

Truist Securities Downgrades Devon Energy to Hold, Lowers Price Target to $43

Earnings Beats

Earnings Misses

TBLA

Taboola.com Q3 2024 Adj. EPS $0.06 Misses $0.08 Estimate, Sales $433.012M Beat $429.435M Estimate

Liberty TripAdvisor Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRPA#NASDAQ">LTRPA</a>) reported quarterly earnings of $0.05 per share. This is a 101.64 percent increase over losses of $(3.04) per share from the same period last year. The company reported $532.00 million in sales this quarter. This is a 0.19 percent decrease over sales of $533.00 million the same period last year.

LTRPA

Liberty TripAdvisor Hldgs Q3 EPS $0.05 Up From $(3.04) YoY, Sales $532.00M Down From $533.00M YoY

Guidance
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">$ in millions</td>
<td colspan="1" rowspan="1">FY 2024</td>
<td colspan="1" rowspan="1">FY 2023</td>
<td colspan="1" rowspan="1">YoY Change</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue1</td>
<td colspan="1" rowspan="1">~$794</td>
<td colspan="1" rowspan="1">$750.3</td>
<td colspan="1" rowspan="1">~6%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Revenue1</td>
<td colspan="1" rowspan="1">~$794</td>
<td colspan="1" rowspan="1">$760.3</td>
<td colspan="1" rowspan="1">~4%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA3</td>
<td colspan="1" rowspan="1">$255 - $260</td>
<td colspan="1" rowspan="1">$217.4</td>
<td colspan="1" rowspan="1">17% - 20%</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;

GDRX

GoodRx Expects 2024 Sales Of Around $794M Vs. $800.798M

Morgan Stanley analyst Joseph Moore initiates coverage on Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Equal-Weight rating and announces Price Target of $21.

Initiation

ALGM

Morgan Stanley Initiates Coverage On Allegro Microsystems with Equal-Weight Rating, Announces Price Target of $21

OppFi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPFI#NYSE">OPFI</a>) raises FY2024 Adj EPS guidance from $0.73-0.75 to $0.85-0.87 vs $0.74 analyst estimate. Affirms FY2024 sales outlook from $510.00 million-530.00 million to $510.00 million-530.00 million vs $518.97 million estimate.

OPFI

OppFi Raises FY2024 Adj EPS Guidance from $0.73-0.75 to $0.85-0.87 vs $0.74 Est; Affirms FY2024 Sales Guidance  to $510.00M-530.00M vs $518.97M Est

"We will continue to execute on our business model that is focused on long-term brand-building and leveraging our cash generation. With this proven strategy and strong balance sheet we are well positioned to maximize shareholder value through disciplined capital deployment," Mr. Lombardi concluded.
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Fiscal 2025 Outlook</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Revenue</td>
<td>$1,125 to $1,140 million</td>
</tr>
<tr>
<td>Organic Revenue Growth</td>
<td>Approximately 1%</td>
</tr>
<tr>
<td>Adjusted Diluted E.P.S.</td>
<td>$4.40 to $4.46</td>
</tr>
<tr>
<td>Free Cash Flow</td>
<td>$240 million or more</td>
</tr>
</tbody>
</table>
</figure>

Prestige Consumer Affirms FY25 GAAP EPS Guidance Of $4.40-$4.46 vs $4.49 Est; Sales Of $1.13B-1.14B vs $1.14B Est

HC Wainwright &amp; Co. analyst Scott Buck reiterates Mogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOGO#NASDAQ">MOGO</a>) with a Buy and maintains $6 price target.

MOGO

HC Wainwright & Co. Reiterates Buy on Mogo, Maintains $6 Price Target

PG&E Sees FY25 Core EPS Of $1.47 to $1.51 Vs. $1.48 Est.

LFST

LifeStance Sees FY24 Revenue $1.228B-$1.248B Vs $1.225B Estimate; Sees Q4 2024 Revenue $302.5M-$322.5M Vs $310.78M Estimate

Analysts have been eager to weigh in on the Communication Services sector with new ratings on Beachbody Company (BODI – Research Report), Spotify T...

Analysts Have Conflicting Sentiments on These Communication Services Companies: Beachbody Company (BODI), Spotify Technology SA (SPOT) and Enthusiast Gaming Holdings (OtherEGLXF)

The Beachbody Company, Inc. (BODI) Q2 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Fox (FOXA – Research Report) and Beachbo...

Analysts Offer Insights on Communication Services Companies: Fox (FOXA) and Beachbody Company (BODI)

Backblaze names Marc Sidan as CFO

Beachbody Company (BODI) just unveiled an update. Brad Ramberg, upon his appointment as Interim CFO for The Beachbody Company, Inc. on August 15, 2...

Beachbody Appoints New Interim CFO with Equity Incentive

Beachbody Company (BODI – Research Report), the Communication Services sector company, was revisited by a Wall Street analyst yesterday. Analyst Su...

Buy Rating on Beachbody Company: Strong Growth Potential in the Booming Nutrition Market

In a report released yesterday, Susan Anderson from Canaccord Genuity maintained a Buy rating on Beachbody Company (BODI – Research Report), with a...

Buy Rating Affirmed for Beachbody on Strategic HSA/FSA Partnership with Truemed

The Beachbody Company to reduce workforce by 33%

The latest announcement is out from Beachbody Company ( ($BODI) ). The Beachbody Company, Inc. is overhauling its business approach by shifting fro...

Beachbody Company Shifts Strategy for Profitable Growth

Analyst Susan Anderson from Canaccord Genuity maintained a Buy rating on Beachbody Company (BODI – Research Report) and keeping the price target at...

Comments

Beachbody Co

Vendite allo scoperto

Beachbody Co (NYSE:BODI) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO